The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia) (Lancet, 1997)
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy